Aberdeen Group plc Boosts Stock Position in Integral Ad Science Holding Corp. $IAS

Key Points

• Aberdeen Group plc increased its shares in Integral Ad Science by 12.7% during Q1, now holding approximately 1.22% of the company valued at $16.08 million.
• Integral Ad Science reported a net revenue of $149.20 million for the last quarter, exceeding analysts' expectations of $143.02 million.
• The company's stock has a market capitalization of $1.55 billion, with shares opening at $9.30, reflecting a 52-week range between $6.26 and $13.62.

Aberdeen Group plc boosted its holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 12.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,994,980 shares of the company's stock after buying an additional 224,153 shares during the period. Aberdeen Group plc owned 1.22% of Integral Ad Science worth $16,080,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Integral Ad Science by 4.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,519 shares of the company's stock worth $433,000 after buying an additional 1,832 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in shares of Integral Ad Science by 7.4% in the 4th quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company's stock valued at $332,000 after purchasing an additional 2,188 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of Integral Ad Science by 547.1% in the 1st quarter. GAMMA Investing LLC now owns 3,313 shares of the company's stock valued at $270,000 after purchasing an additional 2,801 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Integral Ad Science by 1.7% in the 4th quarter. Renaissance Technologies LLC now owns 207,600 shares of the company's stock valued at $2,167,000 after purchasing an additional 3,400 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its stake in shares of Integral Ad Science by 17.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,997 shares of the company's stock valued at $293,000 after purchasing an additional 4,099 shares in the last quarter. 95.78% of the stock is owned by institutional investors and hedge funds.

Integral Ad Science Stock Performance

Shares of NASDAQ:IAS traded up $0.34 during mid-day trading on Friday, hitting $9.25. 909,697 shares of the company traded hands, compared to its average volume of 908,896. The firm has a market cap of $1.54 billion, a P/E ratio of 27.21, a PEG ratio of 1.34 and a beta of 1.57. Integral Ad Science Holding Corp. has a 52-week low of $6.26 and a 52-week high of $13.62. The firm's 50 day simple moving average is $8.38 and its 200 day simple moving average is $8.41.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.04 by $0.03. Integral Ad Science had a return on equity of 5.00% and a net margin of 9.79%.The business had revenue of $149.20 million for the quarter, compared to the consensus estimate of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Insider Transactions at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 9,922 shares of Integral Ad Science stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $8.12, for a total transaction of $80,566.64. Following the sale, the chief executive officer directly owned 380,557 shares in the company, valued at $3,090,122.84. The trade was a 2.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In the last quarter, insiders sold 35,073 shares of company stock worth $289,641. 2.00% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Stifel Nicolaus lifted their price objective on Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. Barclays lifted their price objective on Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a research note on Friday, August 8th. Raymond James Financial reduced their price objective on Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Finally, Wall Street Zen raised Integral Ad Science from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $13.55.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.